Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Scrutinizers' Report for EGM_December 29, 2022
December 30, 2022
Disclosure_Revised standard for Credit Rating_December 2022
December 24, 2022
Investor Presentation_December 16, 2022
December 16, 2022
Intimation under Regulation 30_December 15, 2022
December 15, 2022
Newspaper Advertisement on EGM Notice (FE)
December 7, 2022
Newspaper Advertisement on EGM Notice (Makkal Kural)
December 7, 2022
EGM Notice_December 2022
December 6, 2022
Intimation of EGM Date and Remote E-Voting_December 2022
December 2, 2022
Board Meeting Outcome_December 1, 2022
December 1, 2022
Press Release under Regulation 30_December 1, 2022
December 1, 2022
Corrigendum to Press Release_December 1, 2022
December 1, 2022
Related Party Transactions_September 30, 2022
November 28, 2022
Intimation of Board Meeting_November 28, 2022
November 28, 2022
Transcript of Earnings conference call_Q2 FY 2023
November 23, 2022
Investor Call Outcome_September 30, 2022
November 18, 2022
Investor Presentation_September 30, 2022
November 18, 2022
Previous
1
...
Next
14 / 36